Chronic immunoglobulin maintenance therapy in myasthenia gravis-Reference-Cited by-同舟云学术

Chronic immunoglobulin maintenance therapy in myasthenia gravis

Published:2020-10-15 Issue:2 Volume:28 Page:639-646
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Alcantara M.¹^ORCID,Sarpong E.¹,Barnett C.¹,Katzberg H.¹,Bril V.¹^ORCID

Affiliation:

1. Ellen and Martin Prosserman Centre for Neuromuscular Diseases Toronto General Hospital University Health NetworkUniversity of Toronto Toronto ON Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14547

Reference32 articles.

1. Advances in autoimmune myasthenia gravis management

2. Myasthenia gravis: Historical achievements and the “golden age” of clinical trials

3. Diagnostic and clinical classification of autoimmune myasthenia gravis

4. Myasthenia gravis: subgroup classification and therapeutic strategies

5. International consensus guidance for management of myasthenia gravis

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis;Journal of Comparative Effectiveness Research;2024-09

2. Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment;European Journal of Neurology;2024-02-06

3. Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future;CNS Drugs;2024-01

4. Myasthenia gravis—Pathophysiology, diagnosis, and treatment;Handbook of Clinical Neurology;2024

5. Myasthenia gravis: Molecular mechanisms and promising therapeutic strategies;Biochemical Pharmacology;2023-12